One of the biggest challenges in treating neurodegenerative diseases is delivering suitable anti-inflammatory and antioxidant agents to the brain. Nutaria's patented intranasal nanotechnology bypasses the blood-brain barrier (BBB), enabling precise delivery of naturally derived phytochemicals directly to targeted brain areas. This innovative approach ensures therapeutic compounds reach the regions most affected by neurodegeneration, offering a breakthrough in early intervention and prevention. By focusing on targeted delivery, we are significantly enhancing the effectiveness of treatments for neurodegenerative conditions.